The Global Preventive Vaccines Market Is Projected To Be Worth USD 94 Billion, By 2030, Growing At A CAGR Of 10.7%, Claims Roots Analysis

>

The global preventive vaccines market is projected to be worth USD 94 billion, by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

Roots Analysis has done a detailed report on Global Preventive Vaccines Market, 2020-2030”, covering key aspects of the industry and identifying potential future growth opportunities.

 

To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

 

Key Market Insights

  • More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development
  • A variety of vaccine APIs, designed for administration via multiple routes of delivery, are presently being investigated; most such candidates are in the early stages of development
  • In order to achieve a competitive edge, vaccine developers are putting in significant efforts to ensure that their candidates are clinically and commercially competent
  • Foreseeing a lucrative future in this domain, several private and public investors have invested close to USD 10 billion in vaccine development initiatives, across 170 instances, in the time period between 2015 and 2020
  • Over the last few years, 1,400+ clinical trials evaluating various types of preventive vaccines have been registered, indicating the rapid pace of development in this field
  • Case-in-Point: Around 70 companies, situated in different regions across the globe, claim to provide contract development, fill / finish and regulatory support, in addition to manufacturing services
  • The market is anticipated to grow at a CAGR of 10.7%, till 2030, and the projected opportunity is likely to be distributed across various routes of administration, vaccine types and key geographical regions

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

 

Table of Contents

 

  1. PREFACE
    1.1. Scope of the Report
    1.2.       Research Methodology
    1.3.       Chapter Outlines

    2.         EXECUTIVE SUMMARY

  2. INTRODUCTION

3.1.       Chapter Overview

3.2.       Preventive Vaccines

3.2.1.    Classification of Vaccines

3.2.1.1. Live, Attenuated Vaccines

3.2.1.2. Inactivated Vaccines

3.2.1.3. Subunit Vaccines

3.2.1.4. Toxoid Vaccines

3.2.1.5. DNA Vaccines

 

3.2.2.    Key Components of a Vaccine Formulation

3.2.3.    Production of Vaccines using Different Expression Systems

3.2.3.1. Embryonated Chicken Eggs and Primary Chicken Embryonic Fibroblasts (CEFs)

3.2.3.2. Mammalian Expression Systems

3.2.3.3. Avian Expression Systems

3.2.3.4. Plant Expression Systems

3.2.3.5. Bacterial Expression Systems

3.2.3.6. Yeast Expression Systems

3.2.3.7. Insect Expression System

 

3.2.4.    Routes of Vaccine Administration

3.2.4.1. Intramuscular Route

3.2.4.2. Subcutaneous Route

3.2.4.3. Oral Route

3.2.4.4. Intranasal Route

3.2.4.5. Intradermal Route

3.2.4.6. Inhalation

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global

Comments